QC
MRNA icon

Quadrature Capital’s Moderna MRNA Stock Holding History

Quadrature Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-78,311
Closed -$2.31M – 1683
2025
Q4 		$2.31M Sell
78,311
-67,742
-46% -$1.84M 0.02% 341
2025
Q3 		$3.77M Buy
146,053
+80,710
+124% +$2.25M 0.04% 225
2025
Q2 		$1.8M Sell
65,343
-111,313
-63% -$2.93M 0.03% 311
2025
Q1 		$5M Buy
+176,656
New +$6.27M 0.11% 173

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quadrature Capital's MRNA Position: Q1 2026 in Review

Quadrature Capital sold out of Moderna (MRNA) in Q1 2026, closing a stake of 78,311 shares — an estimated $2.31M sold.

Quadrature Capital first reported a position in MRNA in Q1 2025 and held it in 4 quarters. The position peaked at $5M in Q1 2025. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Quadrature Capital reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 78,311 Moderna shares in Q1 2026, an estimated $2.31M.
  • Quadrature Capital first reported a position in Moderna in Q1 2025 and held it in 4 quarters.
  • Quadrature Capital's Moderna position peaked at $5M in Q1 2025.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.